PEAK6 Group’s Epizyme, Inc EPZM Stock Holding History

PEAK6 Group’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,164	Closed	-$156K	–	5459
2015 Q3	$156K	Buy	+12,164	New	+$245K	﹤0.01%	3956

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Group's EPZM Position: Q4 2015 in Review

PEAK6 Group sold out of Epizyme, Inc (EPZM) in Q4 2015, closing a stake of 12,164 shares — an estimated $156K sold.

PEAK6 Group first reported a position in EPZM in Q3 2015 and held it in 1 quarter. The position peaked at $156K in Q3 2015. 89 funds tracked by Wall St. Rank hold EPZM as of Q4 2015.

PEAK6 Group reported no remaining Epizyme, Inc position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 12,164 Epizyme, Inc shares in Q4 2015, an estimated $156K.
PEAK6 Group first reported a position in Epizyme, Inc in Q3 2015 and held it in 1 quarter.
PEAK6 Group's Epizyme, Inc position peaked at $156K in Q3 2015.
89 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.